ストックスクリーナーアプリを入手
90.17
2.61%
2.29
アフターアワーズ：
90.17
前日終値:
$87.88
開ける：
$88.89
24時間の取引高:
614.12K
Relative Volume:
0.72
時価総額：
$5.44B
収益：
$521.31M
当期純損益:
$-23.36M
株価収益率:
-188.60
EPS:
-0.4781
ネットキャッシュフロー:
$54.87M
1週間 パフォーマンス:
-1.63%
1か月 パフォーマンス:
-16.99%
6か月 パフォーマンス:
+22.56%
1年 パフォーマンス:
+91.61%
1日の値動き範囲:
$88.35
$91.73
1週間の範囲:
$84.94
$94.16
52週間の値動き範囲:
$36.88
$109.28
Mirum Pharmaceuticals Inc Stock (MIRM) Company Profile
名前
Mirum Pharmaceuticals Inc
セクター
電話
650-667-4085
住所
989 EAST HILLSDALE BOULEVARD, SUITE 300, FOSTER CITY
Compare MIRM vs VRTX, REGN, ALNY, ARGX, INSM
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
MIRM
Mirum Pharmaceuticals Inc
|
90.17 | 5.30B | 521.31M | -23.36M | 54.87M | -0.4781 |
VRTX
Vertex Pharmaceuticals Inc
|
454.97 | 113.96B | 12.07B | 3.95B | 3.19B | 15.33 |
REGN
Regeneron Pharmaceuticals Inc
|
749.47 | 78.41B | 14.34B | 4.50B | 3.77B | 41.56 |
ALNY
Alnylam Pharmaceuticals Inc
|
328.70 | 40.85B | 3.71B | 313.75M | 465.38M | 2.2571 |
ARGX
Argen X Se Adr
|
697.05 | 42.05B | 4.16B | 1.29B | 734.26M | 19.58 |
INSM
Insmed Inc
|
148.31 | 29.99B | 606.42M | -1.28B | -997.58M | -6.403 |
Mirum Pharmaceuticals Inc Stock (MIRM) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2026-02-18 | 開始されました | RBC Capital Mkts | Outperform |
| 2025-09-24 | 開始されました | TD Cowen | Buy |
| 2025-08-11 | 再開されました | Stifel | Buy |
| 2025-05-19 | 再開されました | H.C. Wainwright | Buy |
| 2024-04-17 | 開始されました | Stifel | Buy |
| 2023-12-18 | 繰り返されました | H.C. Wainwright | Buy |
| 2023-11-20 | 再開されました | JP Morgan | Overweight |
| 2023-11-13 | 開始されました | Morgan Stanley | Overweight |
| 2023-10-24 | 開始されました | Cantor Fitzgerald | Overweight |
| 2023-10-17 | 再開されました | Evercore ISI | Outperform |
| 2023-09-20 | 開始されました | JMP Securities | Mkt Outperform |
| 2022-09-01 | 開始されました | Citigroup | Buy |
| 2021-09-20 | 開始されました | JP Morgan | Overweight |
| 2020-08-07 | アップグレード | Raymond James | Outperform → Strong Buy |
| 2020-08-03 | 開始されました | H.C. Wainwright | Buy |
| 2020-07-31 | 開始されました | Piper Sandler | Overweight |
| 2020-06-25 | 開始されました | Robert W. Baird | Outperform |
| 2019-08-12 | 開始されました | Citigroup | Buy |
| 2019-08-12 | 開始されました | Evercore ISI | Outperform |
| 2019-08-12 | 開始されました | Guggenheim | Buy |
| 2019-08-12 | 開始されました | ROTH Capital | Buy |
| 2019-08-12 | 開始されました | Raymond James | Outperform |
すべてを表示
Mirum Pharmaceuticals Inc (MIRM) 最新ニュース
Investor Mood: What are analysts price targets for Mirum Pharmaceuticals Inc2026 Institutional Moves & High Accuracy Trade Alerts - baoquankhu1.vn
Mirum completes enrollment & screening in liver disease studies - MSN
Citizens reiterates Mirum Pharmaceuticals stock rating ahead of data By Investing.com - Investing.com Canada
Mirum Pharmaceuticals (NASDAQ:MIRM) Receives Buy Rating from HC Wainwright - MarketBeat
Mirum Gains 35% in 3 Months: How Should You Play the Stock? - MSN
Is Mirum Pharmaceuticals (NASDAQ:MIRM) Stabilizing After Rating Updates? - Kalkine Media
Mirum Pharmaceuticals (MIRM) completes enrollment for phase 3 EXPAND study of LIVMARLI - MSN
Baird updates Mirum Pharmaceuticals (MIRM) valuation following beat-and-raise earnings results - MSN
Biotech Stock Up 372% Gets Sold as New Pick Rises 40% in 2026 - The Motley Fool
Mirum Pharmaceuticals (MIRM) Completes Enrollment for Phase 3 EXPAND Study of LIVMARLI - Insider Monkey
Responsive Playbooks and the MIRM Inflection - Stock Traders Daily
MIRM Stock Price, Quote & Chart | MIRUM PHARMACEUTICALS INC (NASDAQ:MIRM) - ChartMill
MIRM SEC FilingsMirum Pharmaceuticals 10-K, 10-Q, 8-K Forms - Stock Titan
5 Most Promising Stocks Under $100 to Buy - Insider Monkey
RBC Capital initiates coverage of Mirum Pharmaceuticals (MIRM) with outperform recommendation - MSN
Why Mirum Pharmaceuticals Stock Is Sinking Today - TipRanks
Penn Capital Management Company LLC Sells 34,265 Shares of Mirum Pharmaceuticals, Inc. $MIRM - MarketBeat
Mirum EXPAND Enrollment Milestone Highlights LIVMARLI Upside And Valuation Gap - Yahoo Finance
Mirum Pharmaceuticals (NASDAQ:MIRM) Insider Joanne Quan Sells 7,287 Shares - MarketBeat
Insider Selling: Mirum Pharmaceuticals (NASDAQ:MIRM) COO Sells 16,515 Shares of Stock - MarketBeat
Insider Selling: Mirum Pharmaceuticals (NASDAQ:MIRM) CFO Sells $670,258.26 in Stock - MarketBeat
Mirum Pharma’s chief medical officer Quan sells $670k in stock - Investing.com Canada
Mirum Pharmaceuticals Executives Sell Shares - TradingView
Mirum (NASDAQ: MIRM) CFO exercises performance RSUs, sells shares to cover tax withholding - Stock Titan
Mirum (MIRM) CMO exercises performance RSUs, sells 7,287 shares for tax - Stock Titan
[Form 4] Mirum Pharmaceuticals, Inc. In... - Stock Titan
Mirum (MIRM) president sells 16,515 shares, exercises 30,220 RSUs - Stock Titan
Mirum (NASDAQ: MIRM) SVP exercises PRSUs, sells 4,732 shares for taxes - Stock Titan
Mirum (MIRM) CEO sells shares to cover tax from RSU vesting - Stock Titan
Mirum Pharmaceuticals (NASDAQ: MIRM) files to sell 7,287 vested RSU shares - Stock Titan
Joanne Quan to Sell 7,287 Mirum Shares (NASDAQ: MIRM) via Morgan Stanley - Stock Titan
Mirum Pharmaceuticals (NASDAQ: MIRM) insider files to sell 16,515 shares - Stock Titan
Mirum Pharmaceuticals (MIRM) files Form 144: proposed resale of vested RSUs - Stock Titan
Mirum Pharmaceuticals (NASDAQ: MIRM) insider sells vested RSUs totaling multiple transactions - Stock Titan
Mirum Completes Enrollment in Late-Stage EXPAND Study of Livmarli - The Globe and Mail
Citizens reiterates Mirum Pharmaceuticals stock rating on trial progress - Investing.com
Aquatic Capital Management LLC Boosts Stock Holdings in Mirum Pharmaceuticals, Inc. $MIRM - MarketBeat
Mirum completes enrollment in cholestatic pruritus trial By Investing.com - Investing.com India
Trading Recap: Is Mirum Pharmaceuticals Inc a turnaround story2026 Breakouts & Breakdowns & Fast Gain Stock Tips - baoquankhu1.vn
Mirum Pharmaceuticals releases latest announcement details - Traders Union
Saira Ramasastry to sell 2,000 shares via option exercise (NASDAQ: MIRM) - Stock Titan
Mirum Pharmaceuticals Completes Enrollment in Phase 3 EXPAND Study of LIVMARLI® (maralixibat) in Additional Rare Cholestatic Liver Diseases - BioSpace
Mirum completes enrollment in cholestatic pruritus trial - Investing.com
Algert Global LLC Buys 31,250 Shares of Mirum Pharmaceuticals, Inc. $MIRM - MarketBeat
Eventide Asset Management LLC Sells 114,922 Shares of Mirum Pharmaceuticals, Inc. $MIRM - MarketBeat
Mirum Pharmaceuticals, Inc. $MIRM Stock Holdings Reduced by Boone Capital Management LLC - MarketBeat
Mirum Pharmaceuticals, Inc. $MIRM Shares Bought by Connor Clark & Lunn Investment Management Ltd. - MarketBeat
Aug Patterns: Can Mirum Pharmaceuticals Inc benefit from deglobalization2026 Catalysts & Weekly Breakout Watchlists - baoquankhu1.vn
How Investors Are Reacting To Travere Therapeutics (TVTX) FILSPARI Momentum And Mirum Milestone Windfall - simplywall.st
Does Advancing Brelovitug Into Late-Stage HDV Trials Change The Bull Case For Mirum Pharmaceuticals (MIRM)? - simplywall.st
Mirum Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - The AI Journal
Mirum Pharmaceuticals Inc (MIRM) 財務データ
収益
当期純利益
現金流量
EPS
1.82%
大文字化:
|
ボリューム (24 時間):